| 681788 |
FRONTIERS IN ONCOLOGY |
Allicin and Digestive System Cancers: From Chemical Structure to Its Therapeutic Opportunities |
2021-04-27 |
10.3389/fonc.2021.650256 |
Sarvizadeh Mahshad, Hasanpour Omid, Naderi Ghale-Noie Zari, Mollazadeh Samaneh, Rezaei Mohammad, Pourghadamyari Hossein, Masoud Khooy Mohammadjaber, Aschner Michael, Khan Haroon, Rezaei Nima, Shojaie Layla, Mirzaei Hamed |
| 681787 |
FRONTIERS IN ONCOLOGY |
Identification and Validation of SNP-Containing Genes With Prognostic Value in Gastric Cancer via Integrated Bioinformatics Analysis |
2021-04-27 |
10.3389/fonc.2021.564296 |
Li Hui, Guo Jing, Cheng Guang, Wei Yucheng, Liu Shihai, Qi Yaoyue, Wang Gongjun, Xiao Ruoxi, Qi Weiwei, Qiu Wensheng |
| 681786 |
FRONTIERS IN ONCOLOGY |
Malignant Pleural Effusions—A Window Into Local Anti-Tumor T Cell Immunity? |
2021-04-27 |
10.3389/fonc.2021.672747 |
Principe Nicola, Kidman Joel, Lake Richard A., Lesterhuis Willem Joost, Nowak Anna K., McDonnell Alison M., Chee Jonathan |
| 681785 |
FRONTIERS IN ONCOLOGY |
Cost-Effectiveness Analysis of Atezolizumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer With Different PD-L1 Expression Status |
2021-04-27 |
10.3389/fonc.2021.669195 |
Liu Guoqiang, Kang Shuo, Wang Xinchen, Shang Fangjian |
| 681784 |
FRONTIERS IN ONCOLOGY |
miR-1301-3p Promotes Cell Proliferation and Facilitates Cell Cycle Progression via Targeting SIRT1 in Gastric Cancer |
2021-04-27 |
10.3389/fonc.2021.664242 |
Luo Dakui, Fan Hao, Ma Xiang, Yang Chao, He Yu, Ge Yugang, Jiang Mingkun, Xu Zekuan, Yang Li |
| 681783 |
FRONTIERS IN ONCOLOGY |
The G4 Resolvase DHX36 Possesses a Prognosis Significance and Exerts Tumour Suppressing Function Through Multiple Causal Regulations in Non-Small Cell Lung Cancer |
2021-04-27 |
10.3389/fonc.2021.655757 |
Cui Yuxin, Li Zhilei, Cao Junxia, Lane Jane, Birkin Emily, Dong Xuefei, Zhang Lijian, Jiang Wen G. |
| 681782 |
FRONTIERS IN ONCOLOGY |
Genomic Analysis of Glioblastoma Multiforme Reveals a Key Transcription Factor Signature Relevant to Prognosis and the Immune Processes |
2021-04-27 |
10.3389/fonc.2021.657531 |
Li Zhen-Hang, Guan Yan-Lei, Zhang Guo-Bin |
| 681781 |
FRONTIERS IN ONCOLOGY |
TERT-Promoter Mutational Status in Glioblastoma – Is There an Association With Amino Acid Uptake on Dynamic 18F-FET PET? |
2021-04-27 |
10.3389/fonc.2021.645316 |
Unterrainer Marcus, Ruf Viktoria, von Rohr Katharina, Suchorska Bogdana, Mittlmeier Lena Maria, Beyer Leonie, Brendel Matthias, Wenter Vera, Kunz Wolfgang G., Bartenstein Peter, Herms Jochen, Niyazi Maximilian, Tonn Jörg C., Albert Nathalie Lisa |
| 681780 |
FRONTIERS IN ONCOLOGY |
Initial Experience of Intentional Internal High-Dose Policy Volumetric Modulated Arc Therapy of Neck Lymph Node Metastases ≥ 2 cm in Patients With Head and Neck Squamous Cell Carcinoma |
2021-04-27 |
10.3389/fonc.2021.651409 |
Kashihara Tairo, Nakamura Satoshi, Murakami Naoya, Ito Kimiteru, Matsumoto Yoshifumi, Kobayashi Kenya, Omura Go, Mori Taisuke, Honma Yoshitaka, Kubo Yuko, Okamoto Hiroyuki, Takahashi Kana, Inaba Koji, Okuma Kae, Igaki Hiroshi, Nakayama Yuko, Kato Ken, Matsumoto Fumihiko, Yoshimoto Seiichi, Itami Jun |
| 681779 |
FRONTIERS IN ONCOLOGY |
Inferring Cell Subtypes and LncRNA Function by a Cell-Specific CeRNA Network in Breast Cancer |
2021-04-27 |
10.3389/fonc.2021.656675 |
Chen Xin, Xu Jing, Zeng Feng, Yang Chao, Sun Weijun, Yu Tao, Zhang Haokun, Li Yan |
